Mutated <i>BCR-ABL</i> Generates Immunogenic T-cell Epitopes in CML Patients

Abstract

Our in vitro studies support the hypothesis that leukemia-driven genetic alterations are targeted by the immune system in association with a clinical response, and suggest the possibility of immunizing relapsed patients with CML against newly acquired tumor neoantigens.